SYnAbs enters in India!


SYnAbs is proud to announce a strategic deal with successful company OSB India which already distributes significant references in the field of monoclonal antibodies and will consequently extend its catalog with unique mAbs references from SYnAbs.


Under the terms of the agreement, OSB India will have access to the unique portfolio of rats and guinea pigs mAbs to address Indian territory needs in R&D and In Vitro Diagnostics fields.